New targets for allergic rhinitis — a disease of civilization
- 1 November 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (11) , 903-915
- https://doi.org/10.1038/nrd1224
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Mast cells: Beyond IgEJournal of Allergy and Clinical Immunology, 2003
- Unraveling the mission of FcϵRI on antigen-presenting cellsJournal of Allergy and Clinical Immunology, 2003
- Cysteinyl leukotriene receptorsProstaglandins & Other Lipid Mediators, 2002
- Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fallAnnals of Allergy, Asthma & Immunology, 2002
- Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2002
- The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitisJournal of Allergy and Clinical Immunology, 2001
- Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes TH1 cytokine expression while downregulating TH2 cytokine expression in PBMCs from human patients with ragweed allergyJournal of Allergy and Clinical Immunology, 2001
- Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airwaysJournal of Allergy and Clinical Immunology, 2001
- Molecular pathology of allergic disease: II: Upper airway diseaseJournal of Allergy and Clinical Immunology, 2000
- Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocationJournal of Allergy and Clinical Immunology, 1999